Characterization of cognitive impairment in adult polyglucosan body disease

Paul Theo Zebhauser, Isabell Cordts, Holger Hengel, Bernhard Haslinger, Paul Lingor, Hasan Orhan Akman, Tobias B. Haack, Marcus Deschauer

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in GBE1. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptoms and dementia have been reported in APBD but have not been studied systematically. Using exome sequencing, we identified two previously unreported bi-allelic missense GBE1 variants in a patient with severe memory impairment along with the typical non-cognitive symptoms. We were able to confirm a reduction of GBE1 activity in blood lymphocytes. To characterize the neuropsychological profile of patients suffering from APBD, we conducted a systematic review of cognitive impairment in this rare disease. Analysis of 24 cases and case series (in total 58 patients) showed that executive deficits and memory impairment are the most common cognitive symptoms in APBD.

Original languageEnglish
Pages (from-to)2854-2861
Number of pages8
JournalJournal of Neurology
Volume269
Issue number6
DOIs
StatePublished - Jun 2022

Keywords

  • Adult polyglucosan body disease
  • Cognitive impairment
  • Dementia
  • GBE1
  • Glycogen-branching enzyme

Fingerprint

Dive into the research topics of 'Characterization of cognitive impairment in adult polyglucosan body disease'. Together they form a unique fingerprint.

Cite this